Xue Dong Selected Research

Homoserine Dehydrogenase

10/2021

Biochemical characterization and redesign of the coenzyme specificity of a novel monofunctional NAD+-dependent homoserine dehydrogenase from the human pathogen Neisseria gonorrhoeae.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xue Dong Research Topics

Disease

26	Neoplasms (Cancer) 12/2022 - 01/2013
9	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2017
8	Infections 07/2022 - 06/2003
7	Reperfusion Injury 01/2021 - 09/2017
6	Myocardial Ischemia (Ischemic Heart Diseases) 07/2022 - 09/2017
6	Inflammation (Inflammations) 01/2022 - 01/2016
5	Fibrosis (Cirrhosis) 07/2022 - 01/2021
5	Wounds and Injuries (Trauma) 01/2022 - 01/2018
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2021 - 01/2016
4	Heart Failure 01/2022 - 11/2019
4	Type 2 Diabetes Mellitus (MODY) 08/2021 - 01/2016
4	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021 - 07/2014
4	Alzheimer Disease (Alzheimer's Disease) 02/2020 - 01/2016
3	Mitochondrial Diseases (Mitochondrial Disease) 10/2022 - 01/2021
3	Infarction (Infarctions) 06/2022 - 01/2019
3	COVID-19 01/2022 - 04/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2013
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 07/2018
3	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2017
3	Cognitive Dysfunction 01/2017 - 01/2016
2	Atrial Remodeling 10/2022 - 01/2022
2	Atrial Fibrillation 10/2022 - 01/2022
2	Adenoma (Adenomas) 09/2022 - 01/2022
2	Diabetic Cardiomyopathies 07/2022 - 01/2021
2	Triple Negative Breast Neoplasms 12/2021 - 08/2021
2	Ulcerative Colitis 10/2021 - 07/2021
2	Hemorrhage 08/2021 - 01/2017
2	Seroma 05/2021 - 04/2020
2	Ischemia 01/2021 - 12/2009
2	Melanoma (Melanoma, Malignant) 01/2021 - 11/2018
2	Disease Progression 01/2021 - 01/2020
2	Sleep Wake Disorders 07/2020 - 10/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2019
2	Myocardial Infarction 06/2019 - 01/2018
2	Adenocarcinoma of Lung 01/2019 - 06/2016
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 05/2016
2	Lung Neoplasms (Lung Cancer) 01/2018 - 01/2016
2	Stroke (Strokes) 01/2018 - 12/2009
1	Laryngeal Neoplasms (Laryngeal Cancer) 11/2022
1	Adrenal incidentaloma 09/2022
1	Dehydration (Water Stress) 07/2022
1	Alcoholic Cardiomyopathy 07/2022
1	Cardiomyopathies (Cardiomyopathy) 07/2022
1	Rupture 05/2022

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2018
8	AntigensIBA 12/2022 - 01/2018
8	Pharmaceutical PreparationsIBA 01/2022 - 02/2009
6	Long Noncoding RNAIBA 06/2022 - 01/2019
6	CytokinesIBA 10/2021 - 01/2018
5	EnzymesIBA 01/2022 - 06/2011
4	Peptides (Polypeptides)IBA 06/2022 - 01/2017
4	VaccinesIBA 06/2022 - 06/2003
3	LipidsIBA 09/2022 - 01/2022
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 04/2019
3	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2020
3	MelatoninIBA 01/2022 - 02/2018
3	Hyaluronic Acid (Hyaluronan)IBA 04/2019 - 01/2018
3	MicellesIBA 01/2018 - 01/2018
3	Tyrosine Kinase InhibitorsIBA 06/2016 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 11/2022 - 07/2021
2	polydatinIBA 07/2022 - 01/2018
2	Small Interfering RNA (siRNA)IBA 07/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 05/2013
2	Immune Checkpoint InhibitorsIBA 07/2021 - 01/2020
2	DystrophinIBA 01/2021 - 01/2020
2	Thrombin FDA Link 01/2021 - 01/2020
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 01/2020
2	Imiquimod (Aldara)FDA LinkGeneric 07/2019 - 11/2018
2	Caspase 3 (Caspase-3)IBA 06/2019 - 05/2013
2	naringeninIBA 05/2019 - 01/2019
2	Polysaccharides (Glycans)IBA 01/2019 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 01/2016
2	PolymersIBA 01/2018 - 01/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 12/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 06/2011
2	Antisense OligonucleotidesIBA 10/2015 - 07/2014
1	CarbohydratesIBA 12/2022
1	Carcinoembryonic AntigenIBA 12/2022
1	icariinIBA 10/2022
1	Sirtuin 3IBA 10/2022
1	hydroxide ionIBA 07/2022
1	PTEN-induced putative kinaseIBA 07/2022
1	Cardiotonic Agents (Cardiac Stimulants)IBA 07/2022
1	Dynamins (Dynamin)IBA 07/2022
1	Protein Subunit VaccinesIBA 06/2022
1	Cancer VaccinesIBA 06/2022
1	calcium phosphateIBA 06/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2022
1	Peptide Hydrolases (Proteases)FDA Link 06/2022
1	NanovaccinesIBA 06/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2022
1	Simendan (Levosimendan)IBA 01/2022

Therapy/Procedure

27	Therapeutics 06/2022 - 07/2014
5	Immunotherapy 06/2022 - 01/2018
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
2	Radiotherapy 01/2022 - 12/2019
2	Neoadjuvant Therapy 12/2021 - 08/2021
2	Mastectomy (Mammectomy) 05/2021 - 04/2020
2	Sutures (Suture) 05/2021 - 04/2020